Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation. [electronic resource]
Producer: 20170630Description: 1389-1401 p. digitalISSN:- 1558-3597
- Aged
- Aged, 80 and over
- Anticoagulants -- therapeutic use
- Antithrombins -- therapeutic use
- Asian People
- Atrial Fibrillation -- complications
- Cohort Studies
- Dabigatran -- therapeutic use
- Factor Xa Inhibitors -- therapeutic use
- Female
- Gastrointestinal Hemorrhage -- chemically induced
- Humans
- Intracranial Hemorrhages -- chemically induced
- Male
- Middle Aged
- Retrospective Studies
- Risk Assessment
- Rivaroxaban -- therapeutic use
- Stroke -- mortality
- Thromboembolism -- etiology
- Warfarin -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.